Agency Information Collection Request; 30-Day Public Comment Request, 81211-81212 [2020-27473]
Download as PDF
81211
Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
In-class evaluations .............................................................
Mail/Telephone surveys .......................................................
Focus groups .......................................................................
40,000
12,000
250
1
1
1
40,000
12,000
250
.05
.25
1.50
2,000
3,000
375
Total ..............................................................................
52,250
........................
52,250
........................
5,375
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–27500 Filed 12–14–20; 8:45 am]
OMB No. 0990–New—HHS
Teletracking COVID–19 Portal
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–New]
Agency Information Collection
Request; 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990–New and project title for
reference.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, OS/
DHHS has submitted the following
proposed collection of information to
OMB for review and clearance.
ADDRESSES:
In compliance with the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services, is
announcing it has submitted to the
Office of Management and Budget
(OMB) for review and clearance the
following collection of information.
DATES: Comments on the ICR must be
received on or before January 14, 2021.
SUMMARY:
OMB Control Number
Abstract: The data collected through
this ICR informs the Federal
Government’s understanding of disease
patterns and furthers the development
of policies for prevention and control of
disease spread and impact related to the
2019 Novel Coronavirus (COVID–19).
One of the most important uses of the
data collected through this ICR is to
determine critical allocations of limited
supplies (e.g., protective equipment and
medication). For instance, this
collection has been used to distribute
Remdesivir, a vital therapeutic that HHS
distributes to the American healthcare
system, via distinct data calls on regular
intervals. As of July 10, HHS reduced
the number requests for data from
hospitals to support allocations of
Remdesivir. HHS has stopped sending
out one-time requests for data to aid in
the distribution of Remdesivir or any
other treatments or supplies. This
consolidated daily reporting is the only
mechanism used for the distribution
calculations, and daily reports are
needed to ensure accurate calculations.
Type of Respondent: We acknowledge
the burden placed on many hospitals,
including resource constraints, and have
allowed for some flexibilities, such as
back-submissions or submitting every
business days, with the understanding
that respondents may not have
sufficient staff working over the
weekend. It is our belief that collection
of this information daily is the most
effective way to detect outbreaks and
needs for Federal assistance over time,
by hospital and geographical area, and
to alert the appropriate officials for
action. It’s requested that 5,500
hospitals, submit data daily on the
number of patients tested for COVID–19,
as well as information on bed capacity
and requirements for other supplies.
The HHS Teletracking COVID–19
Portal (U.S. Healthcare COVID–19
Portal) includes some data that were
initially submitted by hospitals to HHS
through CDC’s National Healthcare
Safety Network (NHSN) COVID–19
Module (OMB Control No. 0920–1290,
approved 03/26/2020). Over the last
several months time, the guidance for
which data elements should be sent to
HHS and through which method was
updated at the request of the White
House Coronavirus Task Force and
other leaders to better inform the
response.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
(electronic portal)
Number of
responses per
respondents
Total annual
responses
Average
burden per
response
(in hours)
Total burden
hours
5500 ............
HHS Teletracking COVID–19 Portal ......................................
365
2,007,500
1.75
3,513,125
VerDate Sep<11>2014
17:35 Dec 14, 2020
Jkt 253001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\15DEN1.SGM
15DEN1
81212
Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices
Terry Clark,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 2020–27473 Filed 12–14–20; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Network of
Older Persons with Superior Cognition
Performance.
Date: January 14, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, Two
Democracy Plaza, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Drug Development.
Date: January 22, 2021.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Neural
Network Dysfunction in AD.
Date: February 2, 2021.
Time: 11:30 a.m. to 4:00 p.m.
VerDate Sep<11>2014
17:35 Dec 14, 2020
Jkt 253001
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 9, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Place: National Institute on Aging, Two
Democracy Plaza, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Anita H. Undale, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, Suite 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (301) 827–
7428, anita.undale@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 9, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–27469 Filed 12–14–20; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2020–27494 Filed 12–14–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Oxidative
Stress.
Date: January 19, 2021.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, (301) 496–9667,
nijaguna.prasad@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Pepper Center
May 2021 Council.
Date: February 26, 2021.
Time: 7:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA DK20–016:
Human Pancreas Analysis Program for Type
1 Diabetes—HPAP–T1D.
Date: February 1, 2021.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Video
Meeting).
Contact Person: Najma S. Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7349, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Small Business
Applications T1D Open/Closed Loop
Platforms.
Date: February 12, 2021.
E:\FR\FM\15DEN1.SGM
15DEN1
Agencies
[Federal Register Volume 85, Number 241 (Tuesday, December 15, 2020)]
[Notices]
[Pages 81211-81212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27473]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-New]
Agency Information Collection Request; 30-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department of Health and Human Services,
is announcing it has submitted to the Office of Management and Budget
(OMB) for review and clearance the following collection of information.
DATES: Comments on the ICR must be received on or before January 14,
2021.
ADDRESSES: Submit your comments to [email protected] or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected]
or (202) 795-7714. When submitting comments or requesting information,
please include the document identifier 0990-New and project title for
reference.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, OS/DHHS
has submitted the following proposed collection of information to OMB
for review and clearance.
OMB No. 0990-New--HHS Teletracking COVID-19 Portal
OMB Control Number
Abstract: The data collected through this ICR informs the Federal
Government's understanding of disease patterns and furthers the
development of policies for prevention and control of disease spread
and impact related to the 2019 Novel Coronavirus (COVID-19). One of the
most important uses of the data collected through this ICR is to
determine critical allocations of limited supplies (e.g., protective
equipment and medication). For instance, this collection has been used
to distribute Remdesivir, a vital therapeutic that HHS distributes to
the American healthcare system, via distinct data calls on regular
intervals. As of July 10, HHS reduced the number requests for data from
hospitals to support allocations of Remdesivir. HHS has stopped sending
out one-time requests for data to aid in the distribution of Remdesivir
or any other treatments or supplies. This consolidated daily reporting
is the only mechanism used for the distribution calculations, and daily
reports are needed to ensure accurate calculations.
Type of Respondent: We acknowledge the burden placed on many
hospitals, including resource constraints, and have allowed for some
flexibilities, such as back-submissions or submitting every business
days, with the understanding that respondents may not have sufficient
staff working over the weekend. It is our belief that collection of
this information daily is the most effective way to detect outbreaks
and needs for Federal assistance over time, by hospital and
geographical area, and to alert the appropriate officials for action.
It's requested that 5,500 hospitals, submit data daily on the number of
patients tested for COVID-19, as well as information on bed capacity
and requirements for other supplies.
The HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19
Portal) includes some data that were initially submitted by hospitals
to HHS through CDC's National Healthcare Safety Network (NHSN) COVID-19
Module (OMB Control No. 0920-1290, approved 03/26/2020). Over the last
several months time, the guidance for which data elements should be
sent to HHS and through which method was updated at the request of the
White House Coronavirus Task Force and other leaders to better inform
the response.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Number of respondents Form name responses per Total annual per response Total burden
(electronic portal) respondents responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
5500.................. HHS Teletracking 365 2,007,500 1.75 3,513,125
COVID-19 Portal.
----------------------------------------------------------------------------------------------------------------
[[Page 81212]]
Terry Clark,
Office of the Secretary, Paperwork Reduction Act Reports Clearance
Officer.
[FR Doc. 2020-27473 Filed 12-14-20; 8:45 am]
BILLING CODE 4150-04-P